References
- Peltola L , Pätsi H , Harju T . COPD comorbidities predict high mortality - asthma-COPD-overlap has better prognosis. COPD. 2020;17(4):366–372. doi:10.1080/15412555.2020.1783647
- Mostafavi-Pour-Manshadi S-M-Y , Naderi N , Mancino P , et al. Fractional exhaled nitric oxide as an inflammatory biomarker in chronic obstructive pulmonary disease (COPD) with or without concurrent diagnosis of asthma: the Canadian Cohort Obstructive Lung Disease (CanCOLD). COPD. 2020;17(4):355–365. doi:10.1080/15412555.2020.1779681
- Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention 2020. Last accessed: August 21, 2020. Available from: https://ginasthma.org.
- GINA & GOLD . Diagnosis of diseases of chronic airflow limitation: asthma, COPD and asthma-COPD overlap syndrome (ACOS). 2015. Available from: https://goldcopd.org/asthmacopd-asthma-copd-overlap-syndrome/.
- Diab N , Gershon AS , Sin DD , et al. Underdiagnosis and overdiagnosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2018;198(9):1130–1139. doi:10.1164/rccm.201804-0621CI
- Vanfleteren LEGW , Andersson AE , Fabbri LM . COPD: what's in a name?: mismatch of diagnostic labels and required physiologic features. Chest. 2019;156(2):195–196. doi:10.1016/j.chest.2019.05.008
- Burrows B , Bloom JW , Traver GA , et al. The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. N Engl J Med. 1987;317(21):1309–1314. doi:10.1056/NEJM198711193172103
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of COPD. 2020. Available from: http://goldcopd.org.
- Bateman ED , Reddel HK , van Zyl-Smit RN , et al. The asthma-COPD overlap syndrome: towards a revised taxonomy of chronic airways diseases? Lancet Respir Med. 2015;3(9):719–728. doi:10.1016/S2213-2600(15)00254-4
- Postma DS , Rabe KF . The asthma-COPD overlap syndrome. N Engl J Med. 2015;373(13):1241–1249. doi:10.1056/NEJMra1411863
- Halpin DMG . What is asthma chronic obstructive pulmonary disease overlap? Clin Chest Med. 2020;41(3):395–403. doi:10.1016/j.ccm.2020.06.006
- Mannino DM , Gagnon RC , Petty TL , et al . Obstructive lung disease and low lung function in adults in the United States: data from the National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med. 2000;160(11):1683–1689. doi:10.1001/archinte.160.11.1683
- Backman KS , Greenberger PA , Patterson R . Airways obstruction in patients with long-term asthma consistent with 'irreversible asthma'. Chest. 1997;112(5):1234–1240. doi:10.1378/chest.112.5.1234
- Vonk JM , Jongepier H , Panhuysen CI , et al. Risk factors associated with the presence of irreversible airflow limitation and reduced transfer coefficient in patients with asthma after 26 years of follow up. Thorax. 2003;58(4):322–327. doi:10.1136/thorax.58.4.322
- Fabbri LM , Romagnoli M , Corbetta L , et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167(3):418–424. doi:10.1164/rccm.200203-183OC
- Beeh KM , Westerman J , Kirsten AM , et al. The 24-h lung-function profile of once-daily tiotropium and olodaterol fixed-dose combination in chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2015;32:53–59. doi:10.1016/j.pupt.2015.04.002
- Tashkin DP , Celli B , Senn S , et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med. 2008;359(15):1543–1554. doi:10.1056/NEJMoa0805800
- Hanania NA , Sharafkhaneh A , Celli B , et al. Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial. Respir Res. 2011;12(1):6. doi:10.1186/1465-9921-12-6
- Tashkin DP , Celli B , Decramer M , et al. Bronchodilator responsiveness in patients with COPD. Eur Respir J. 2008;31(4):742–750. doi:10.1183/09031936.00129607
- Nerpin E , Jacinto T , Fonseca JA , et al. Systemic inflammatory markers in relation to lung function in NHANES. 2007–2010. Respir Med. 2018;142:94–100. doi:10.1016/j.rmed.2018.07.011
- Siddiqui SH , Guasconi A , Vestbo J , et al. Blood eosinophils: a biomarker of response to extrafine beclomethasone/formoterol in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;192(4):523–525. doi:10.1164/rccm.201502-0235LE
- Agusti A , Fabbri LM , Singh D , et al. Inhaled corticosteroids in COPD: friend or foe? Eur Respir J. 2018;52(6):1801219. doi:10.1183/13993003.01219-2018